5-HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  European Journal of Pharmacology

• Publication date

  1987-05-07

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/0014-2999(87)90196-8PMID 2956115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increase in slow-wave sleep in humans with the serotonin-S2 antagonist ritanserin: the first exploratory polygraphic sleep study

  1987cited by this paper
• 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep.

  1986cited by this paper
• Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

  1985cited by this paper
• 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA).

  1984cited by this paper
• Hypnogenic indolamine dependent factors and paradoxical sleep rebound introduction

  1983cited by this paper

• Sleep disturbances in autism spectrum disorder: Animal models, neural mechanisms, and therapeutics

  2023cites this paper
• A Cross-Sectional Study on the Relationship Among Cytokines, 5-HT2A Receptor Polymorphisms, and Sleep Quality of Non-manual Workers in Xinjiang, China

  2022cites this paper
• Cannabinoids and sleep-wake cycle: The potential role of serotonin.

  2021cites this paper
• Neurochemistry of sleep

  2021cites this paper
• Drug Discovery in Erectile Dysfunction and Sleep Disorders

  2021cites this paper
• Disinhibition mediated by reciprocal hypothalamic and raphé GABAergic projections promotes wakefulness

  2020cites this paper
• The Serotonergic Raphe Promote Sleep in Zebrafish and Mice.

  2019cites this paper
• Additive effect of 5-HT2C and CB1 receptor blockade on the regulation of sleep–wake cycle

  2019cites this paper
• Selective Serotonin 5-HT2A Receptor Antagonists and Inverse Agonists Specifically Promote Slow Wave Sleep (Stage N3) in Man

  2017cites this paper
• Translational neurophysiological markers for activity of the metabotropic glutamate receptor (mGluR2) modulator JNJ-40411813: Sleep EEG correlates in rodents and healthy men.

  2016cites this paper
• Pharmaco-EEG Studies in Animals: A History-Based Introduction to Contemporary Translational Applications

  2016cites this paper
• The effects of systemic administration and local microinjection into the central nervous system of the selective serotonin 5-HT2C receptor agonist RO-600175 on sleep and wakefulness in the rat

  2015cites this paper
• Sleep Disturbances in Schizophrenia.

  2015cites this paper
• Insomnia Caused by Serotonin Depletion is Due to Hypothermia.

  2015cites this paper
• Investigating epileptiform activity associated with slow wave sleep

  2014cites this paper
• Sleep regulatory factors.

  2014cites this paper
• Sleep, its regulation and possible mechanisms of sleep disturbances

  2013cites this paper
• The Role of 5-HT2A/2C Receptors in Sleep and Waking

  2011cites this paper
• Diltiazem potentiates pentobarbital-induced hypnosis via 5-HT1A and 5-HT2A/2C receptors: role for dorsal raphe nucleus.

  2011cites this paper
• Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.

  2011cites this paper
• Serotonin control of sleep-wake behavior.

  2011cites this paper
• Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia

  2010cites this paper
• Serotonin 5-HT(2A) receptor antagonists in the treatment of insomnia: present status and future prospects.

  2010cites this paper
• Role of 5-HT2A receptor antagonists in the treatment of insomnia

  2010cites this paper
• Discovery of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (nelotanserin) and related 5-hydroxytryptamine2A inverse agonists for the treatment of insomnia.

  2010cites this paper
• Drug Discovery in Non‐Life‐Threatening Disorders: Erectile Dysfunction, Insomnia, and Smoking Cessation

  2010cites this paper
• Rodent models of insomnia: a review of experimental procedures that induce sleep disturbances.

  2009cites this paper
• Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats.

  2008cites this paper
• Contribution of chemosensitive serotonergic neurons to interactions between the sleep-wake cycle and respiratory control

  2008cites this paper
• Changing concepts on the role of serotonin in the regulation of sleep and waking

  2008cites this paper
• 5-HT(2A) inverse-agonists for the treatment of insomnia.

  2008cites this paper
• The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.

  2008influential citation
• Activity of the Serotonergic System During Isoflurane Anesthesia

  2007cites this paper
• Neurochemistry of sleep

  2007cites this paper
• Serotonin and Neuroendocrine Regulation

  2006cites this paper
• Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.

  2006cites this paper
• Human 5-HT2C receptor variants : functional properties and genetic associations in major depressive disorder.

  2005cites this paper
• A comparison of trazodone and fluoxetine: implications for a serotonergic mechanis of antidepressant action

  2005cites this paper
• Effect of dexfenfluramine on sleep in healthy subjects

  2005cites this paper
• Effects of ritanserin and chlordiazepoxide on sleep-wakefulness alterations in rats following chronic cocaine treatment

  2005cites this paper
• Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans

  2005cites this paper
• Effects of ritanserin on sleep disturbances of dysthymic patients

  2004cites this paper
• Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.

  2004cites this paper
• Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat

  2004cites this paper
• Increased wakefulness, motor activity and decreased theta activity after blockade of the 5‐HT2B receptor by the subtype‐selective antagonist SB‐215505

  2004cites this paper
• Brain inhibitory mechanisms involved in basic and higher integrated sleep processes.

  2004cites this paper
• Serotonin receptor mechanisms in anti-depressant action

  2003cites this paper
• Sleep in mental and behavioural disorders

  2003cites this paper
• Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat.

  2003cites this paper
• SLEEP IN MENTAL AND BEHAVIOURAL DISORDERS

  2003cites this paper
• Sleep and Sleep Homeostasis in Mice Lacking the 5-HT2c Receptor

  2002cites this paper
• E¡ect of a single-dose of olanzapine on sleep in healthy females and males

  2002influential citation
• Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine.

  2002cites this paper
• Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift.

  2002cites this paper
• Effect of a single-dose of olanzapine on sleep in healthy females and males

  2002cites this paper
• Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers.

  2002influential citation
• Serotonin and sleep.

  2002cites this paper
• Sleep and Suicide in Psychiatric Patients

  2001cites this paper
• Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.

  2000cites this paper
• Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies.

  2000cites this paper
• Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleep.

  2000cites this paper
• Differential EEG effects of the anxiolytic drugs, deramciclane (EGIS-3886), ritanserin and chlordiazepoxide in rats

  1999cites this paper
• Endogenous and exogenous factors on sleep-wake cycle regulation.

  1999cites this paper
• Prenatal stress is associated with depression-related electroencephalographic sleep changes in adult male rats: a preliminary report.

  1999cites this paper
• The effects of female sex steroids on central serotonergic neurotransmission

  1999cites this paper
• Serotonin plays a permissive role in conditioned olfactory learning induced by norepinephrine in the neonate rat

  1998cites this paper
• Age-related effect of ritanserin on the sleep-waking phases in rats.

  1998cites this paper
• Serotonin plays a permissive role in conditioned olfactory learning induced by norepinephrine in the neonate rat.

  1998cites this paper
• Age-dependent effect of ketanserin on the sleep-waking phases in rats.

  1998cites this paper
• Sleep deprivation increases brain serotonin turnover in the rat

  1997cites this paper
• Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate.

  1997cites this paper
• Induction of sleep.

  1996cites this paper
• Late-afternoon ethanol intake affects nocturnal sleep and the sleep EEG in middle-aged men.

  1996cites this paper
• Bidirectional effect of electromagnetic fields on ketanserin-induced yawning in patients with multiple sclerosis: the role of melatonin.

  1996cites this paper
• The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs.

  1996cites this paper
• Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administration.

  1996cites this paper
• Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopram.

  1996cites this paper
• 5-HT2 receptors are partially involved in the relationship between renin release and delta relative power

  1996cites this paper
• The effect of a 5-hydroxytryptamine antagonist (R51703) on halothane. MAC in the dog.

  1995cites this paper
• Effect of pharmacologic treatments on the sleep of depressed patients.

  1995cites this paper
• Cardiac autonomic function during sleep of never-depressed borderline subjects: a pilot study.

  1995cites this paper
• Effects of sertindole on sleep-wake states, electroencephalogram, behavioral patterns, and epileptic activity of rats.

  1995cites this paper
• Sleep deprivation increases brain serotonin turnover in the Djungarian hamster.

  1995cites this paper
• 5-HT 2C receptor sensitivity during treatment with selective serotonin re-uptake inhibitors

  1994cites this paper
• Central administration of two 5-HT receptor agonists: effect on REM sleep initiation and PGO waves.

  1994cites this paper
• Diurnal differences in L-tryptophan sleep and temperature effects in the rat.

  1994cites this paper
• Effects of 5HT3 Receptor Antagonism by Tropisetron on the Sleep EEG and on Nocturnal Hormone Secretion

  1994cites this paper
• The reliability and functional validity of visual and semiautomatic sleep/wake scoring in the Møll-Wistar rat.

  1994cites this paper
• Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulness.

  1994cites this paper
• Transcallosal evoked potentials: behavior-dependent modulation by muscarinic and serotonergic receptors.

  1994cites this paper
• Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.

  1994cites this paper
• Re‐examination of the effects of raphe lesions on the sleep/wakefulness cycle states in cats

  1993cites this paper
• Serotonin: From Cell Biology to Pharmacology and Therapeutics

  1993cites this paper
• The 5-HT2 antagonist ritanserin decreases sleep in cats.

  1993cites this paper
• Pharmacological Modulation of the Serotonergic System: an Overview of the Effects on Normal and Pathological Sleep

  1993cites this paper
• 5-HT1-like receptor agonists enhance wakefulness.

  1992cites this paper
• Studies on sleep/wake effects of serotonin reuptake inhibitors and receptor subtype involvement

  1992cites this paper
• RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in rats.

  1992cites this paper
• Serotonin (5-HT2) receptor mediated enhancement of cortical unit activity.

  1992cites this paper
• Dose‐dependent effects of the 5‐HT1A receptor agonist 8‐OH‐DPAT on sleep and wakefulness in the rat

  1992cites this paper